Generative AI company Abridge announced a partnership with Northern California-based health system Sutter Health. This will give Sutter's clinicians access to her Abridge clinical documentation software.
Abridge's software is generative AI for clinical conversations that reduces provider workload by automating note-taking.
This software integrates directly into Sutter's Epic EMR system.
The purpose of the Abridge-Sutter partnership is to reduce healthcare worker burnout while improving the patient experience.
”Clinicians often do not have the time to create detailed patient instructions or summaries that reflect the details of the conversation that will be most beneficial to the patient. This is a major use case for generative AI, and we are honored to team with the people at Sutter Health on this new patient-centric initiative,” said Dr. Shibrao, his CEO and founder of Abridge. stated in a statement.
bigger trends
The doctor is Much time is spent on administrative tasks such as writing notes, and administrative workload contributes to physician burnout, which is a major problem in the healthcare ecosystem.
abridge It was launched in 2020 with $15 million in seed funding and Series A funding. The funding round was led by Union Square Ventures and UPMC, with additional funding from Bessemer Venture Partners, Pillar, and KdT Ventures.
In 2022, the medical writing company raised $12.5 million in Series A-1 funding from the same group of investors. Other investors in this round included AI expert Yoshua Bengio and Whistler Capital.
The Pittsburgh-based company announced a $30 million Series B led by: Spark Capital. Spark is backing other genAI companies, including Anthropic, an AI safety and research startup.
In February, Abridge Lightspeed Venture Partners, Redpoint Ventures, CVS Health Ventures. Abridge also announced a partnership with Connecticut-based Yale New Haven Health System. The system will use the company's generative AI solution at hospitals across the state.
Last year, Sutter Health announced it would expand its Research Hatchery, founded in 2017 to explore innovation in healthcare, to create a new San Francisco-based Innovation Center for research and development. .
The health system also expanded its reach to California's Central Coast with the acquisition of the Santa Barbara Sansome Clinic, and in March announced the acquisition of five radiation oncology centers in Northern California.
